Friday, Sep 12, 2025 · SEC filings
What the smart money revealed on Sep 12
493 insider filings came in. We hid 58 planned (10b5-1) sellers and 263 people whose filings were routine, like grants and tax withholding.
Pulse Biosciences (PLSE) Director Robert Duggan bought $2.79M
192,599 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 6 checked quarters beat the typical stock 6 months later.
Bankwell Financial Group (BWFG) Director Lawrence Seidman bought $493K
11,000 shares on the open market. Not a grant or an option exercise. Their past buys: 9 of 10 checked quarters beat the typical stock 6 months later.
Zai Lab (ZLAB) Officer Joshua Smiley bought $289K
10,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 4 checked quarters beat the typical stock 6 months later.
Keurig Dr Pepper (KDP) President Eric Gorli bought $254K
9,175 shares on the open market. Not a grant or an option exercise.
Broadcom (AVGO) President and CEO Hock Tan sold $49.9M
Not marked as a planned 10b5-1 sale. Sold 15% of the shares they held directly. Still holds 825,998 shares.
Rubrik (RBRK) Chairman of the Board and CEO Bipul Sinha sold $46.6M
Not marked as a planned 10b5-1 sale. Sold 75% of the shares they held directly. Still holds 206,652 shares.
Figure Technology Solutions (FIGR) Director Michael Cagney sold $37.5M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 32 more real buys
Show 105 more real sales
13F season
Holdings as of Jun 30, 2025 were due Aug 14
74 funds have filed. 68 filed for the quarter before.
Biggest real insider buys, Sep 6–12
Open-market buys by officers and directors, filed in the 7 days up to Sep 12.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.